Illinois Hospital Report Card

and Consumer Guide to Health Care

Carle Foundation Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 3 infections, 142631 patient days Rating SIR: 0.41	3 infections, 142631 patient days	0.41
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 10 infections, 149189 patient days Rating SIR: 1.16	10 infections, 149189 patient days	1.16
Q1 2021 - Q4 2021 Result 12 infections, 141205 patient days Rating SIR: 1.38	12 infections, 141205 patient days	1.38
Q1 2020 - Q4 2020 Result 4 infections, 124857 patient days Rating SIR: 0.37	4 infections, 124857 patient days	0.37
Q1 2019 - Q4 2019 Result 5 infections, 127660 patient days Rating SIR: 0.52	5 infections, 127660 patient days	0.52
Q1 2018 - Q4 2018 Result 3 infections, 123188 patient days Rating SIR: 0.37	3 infections, 123188 patient days	0.37
Q1 2017 - Q4 2017 Result 4 infections, 115679 patient days Rating SIR: 0.38	4 infections, 115679 patient days	0.38
Q1 2016 - Q4 2016 Result 7 infections, 103909 patient days Rating SIR: 0.90	7 infections, 103909 patient days	0.90
Q1 2015 - Q4 2015 Result 11 infections, 102677 patient days Rating SIR: 1.17	11 infections, 102677 patient days	1.17
Q1 2014 - Q4 2014 Result 10 infections, 105909 patient days Rating SIR: 0.95	10 infections, 105909 patient days	0.95
Q1 2013 - Q4 2013 Result 8 infections, 104792 patient days Rating SIR: 1.10	8 infections, 104792 patient days	1.10
Q1 2012 - Q4 2012 Result 10 infections, 100550 patient days Rating SIR: 1.62	10 infections, 100550 patient days	1.62
Q1 2012 - Q2 2012 Result 6 infections, 49762 patient days Rating SIR: 1.21	6 infections, 49762 patient days	1.21
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 15 infections, 127690 patient days Rating SIR: 0.19	15 infections, 127690 patient days	0.19
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 10 infections, 135087 patient days Rating SIR: 0.13	10 infections, 135087 patient days	0.13
Q1 2021 - Q4 2021 Result 16 infections, 127230 patient days Rating SIR: 0.23	16 infections, 127230 patient days	0.23
Q1 2020 - Q4 2020 Result 20 infections, 111587 patient days Rating SIR: 0.37	20 infections, 111587 patient days	0.37
Q1 2019 - Q4 2019 Result 63 infections, 115683 patient days Rating SIR: 0.78	63 infections, 115683 patient days	0.78
Q1 2018 - Q4 2018 Result 69 infections, 109999 patient days Rating SIR: 0.80	69 infections, 109999 patient days	0.80
Q1 2017 - Q4 2017 Result 72 infections, 103758 patient days Rating SIR: 0.79	72 infections, 103758 patient days	0.79
Q1 2016 - Q4 2016 Result 106 infections, 103711 patient days Rating SIR: 1.22	106 infections, 103711 patient days	1.22
Q1 2015 - Q4 2015 Result 88 infections, 98959 patient days Rating SIR: 0.94	88 infections, 98959 patient days	0.94
Q1 2014 - Q4 2014 Result 78 infections, 98932 patient days Rating SIR: 0.82	78 infections, 98932 patient days	0.82
Q1 2013 - Q4 2013 Result 88 infections, 88843 patient days Rating SIR: 0.99	88 infections, 88843 patient days	0.99
Q1 2012 - Q4 2012 Result 94 infections, 86069 patient days Rating SIR: 1.17	94 infections, 86069 patient days	1.17